| 02/03/20 | Dermira : Form 15-12B - Securities Registration Termination | PU |
| 20/02/20 | Dermira : SEC Filing - S-8 POS | PU |
| 20/02/20 | Dermira : SEC Filing - POS AM | PU |
| 20/02/20 | Dermira : Lilly Completes Acquisition of Dermira | PR |
| 11/02/20 | Dermira : Amended tender offer statement by Third Party | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Thompson
PSD | President | - | - |
Carly Loeb
COO | Chief Operating Officer | - | 31/12/2017 |
Gary Thompson
CMP | Compliance Officer | - | 31/12/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Gordon Brooks
BRD | Director/Board Member | - | 19/02/2020 |
Philip Johnson
BRD | Director/Board Member | 62 | 19/02/2020 |
Michael Thompson
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/02/20 | Don | Chief Medical Officer; Director | 562,325 | 1.0281% | ||
| 20/02/20 | Issuer sale | Director | 68,377 | 0.1250% | ||
| 20/02/20 | Issuer sale | Chief Financial Officer | 496,361 | 0.9075% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.11% | - | - | 1.03B | ||
| +0.19% | -3.96% | +54.92% | +69.15% | 65.42B | ||
| +0.09% | -2.35% | +6.82% | +90.33% | 58.91B | ||
| -0.87% | -0.48% | +25.06% | +85.55% | 55.24B | ||
| -0.97% | -3.91% | +12.98% | +113.88% | 45.66B | ||
| -2.83% | -7.58% | +15.21% | +22.34% | 41.29B | ||
| +3.61% | +2.63% | +21.96% | +46.39% | 36.82B | ||
| -0.24% | -9.59% | +126.05% | +647.44% | 34.48B | ||
| -0.19% | +1.25% | +78.39% | +57.25% | 32.5B | ||
| +20.58% | +22.35% | -29.03% | +482.03% | 31.69B | ||
| Average | +1.92% | -0.39% | +34.71% | +179.38% | 45B | |
| Weighted average by Cap. | +1.41% | -0.98% | +33.29% | +153.89% |
Employees
-
















